60 likes | 189 Views
This audit, led by Dr. David Shutt, assesses osteoporosis management in females aged 65-74 and 74+ with fragility fractures over the past year. The aim is to determine the number of patients who have undergone DEXA scans and are receiving treatment with bone sparing agents. Results showed minimal DEXA scans and treatment in the 65-74 age group, while a few were on treatment in the 74+ category. Changes implemented include contacting patients for review, and future plans involve following guidelines and a re-audit in 12 months.
E N D
Osteoporosis Audit Dr David Shutt
Introduction • Osteoporosis DES • Females age 65-74 who have had fragility # in last 12 months • Have they had a DEXA? • Are they on treatment with a bone sparing agent • Females age 74+ with fragility # in last 12 months • Are they on treatment with bone sparing agent? • “nominated”
Method • Identified patients using computer • Collected data from notes
Results • Number of Fragility fractures • 65 – 74 = 2 • 74+ = 11 • Of those 65 – 74 with # • DEXA scan = 0 • On treatment = 0 • 74+ with # • On treatment = 6 (1 on Ca2+ only and 3 contraindicated)
Changes implemented • Patients who had not had DEXA or Not on treatment if appropriate were contacted for review.
Future Plans • Follow guidelines • Re-Audit in 12 Months